The Claim
“Cut $650 million in bulk billing incentives for pathology.”
Original Sources Provided
✅ FACTUAL VERIFICATION
The claim is factually accurate. In December 2015, the Coalition government announced in its Mid-Year Economic and Fiscal Outlook (MYEFO) that it would remove bulk-billing incentive payments for pathology services, with projected savings of $650 million over four years [1]. The changes were scheduled to take effect on July 1, 2016, for pathology services [2].
The bulk-billing incentives being removed were payments of between $1.40 and $3.40 made directly to pathology service providers to encourage them to bulk-bill patients [2]. The government argued these incentives were being used to cross-subsidise other business costs for large companies (some owned by private equity firms) rather than their intended purpose [2].
The ABC News source provided with the claim is a mainstream, reputable news organization with no significant partisan alignment. The article accurately reports Health Minister Sussan Ley's confirmation that the government would proceed with the cuts despite election timing concerns [1].
Missing Context
The claim omits several important contextual elements:
The incentives were introduced by Labor in 2009. The bulk-billing incentives for pathology were originally introduced by the previous Labor government under Kevin Rudd in 2009 [1]. These were relatively recent additions to the Medicare system, not long-established entitlements.
A deal was struck to offset the impact. In May 2016, the government reached an agreement with Pathology Australia (the industry body representing major providers like Sonic Healthcare and Genea) to introduce rent reforms for Approved Collection Centres [3]. This deal was intended to help pathology providers absorb the cost of losing the bulk-billing incentives by ensuring they paid "fair market value" rents when co-located in GP buildings [2].
The policy rationale. Health Minister Sussan Ley stated the government was "acting in the interests of a sustainable health system" and that the incentives were not meant to subsidise large corporate providers' business costs [1]. The Grattan Institute also noted that with 99% of pathology tests already bulk-billed, there were questions about whether these incentives were still necessary [2].
Uneven impact across providers. Not all pathology providers were treated equally by the rent deal. Catholic Health Australia and other not-for-profit providers argued the deal disproportionately assisted large corporate providers and would not be sufficient to offset cuts for smaller, regional, and rural providers [2].
Source Credibility Assessment
The original source, ABC News (Australian Broadcasting Corporation), is Australia's national public broadcaster. It is:
- A mainstream, reputable news organization
- Funded by taxpayers but governed by an independent board with legislated editorial independence
- Generally regarded as having minimal partisan bias
- Subject to rigorous editorial standards and accountability mechanisms
The ABC article is factual reporting of the Health Minister's statements and the Opposition's response, not an opinion piece. It provides both sides of the debate, making it a credible source for this claim.
Labor Comparison
Did Labor do something similar?
Search conducted: "Labor government pathology bulk billing Medicare policy history"
Finding: Labor actually introduced these incentives in the first place. The bulk-billing incentives for pathology that the Coalition cut were originally introduced by the Rudd Labor government in 2009 [1].
Additionally, the Labor government initiated a Medicare rebate freeze in 2013 (just before losing office), which was then continued by the Coalition government [4]. This pattern shows both parties have taken measures to constrain Medicare spending growth.
Comparative context:
While Labor positioned itself as the defender of bulk-billing during the 2016 election (pledging to reverse the cuts), they also had a history of Medicare cost containment measures. The Coalition's action was to remove an incentive that Labor had created, not to cut a fundamental Medicare benefit.
Balanced Perspective
While the claim accurately states that the Coalition cut $650 million in bulk billing incentives, the full story is more nuanced:
The government's position: The Coalition argued the incentives were being misused by large corporate pathology providers (some owned by private equity) to subsidise other business costs rather than ensuring affordable patient access [2]. With nearly 99% of pathology tests already bulk-billed [2], the government questioned whether the incentives were achieving their intended purpose.
The industry's response: Pathology Australia launched a major "Don't Kill Bulk Bill" campaign, collecting nearly 600,000 signatures [2]. They warned patients would face co-payments, potentially up to $30 per test [1].
The compromise: The government struck a deal with Pathology Australia to regulate rents for collection rooms, which would help providers (particularly large corporate ones) absorb the cuts [2][3].
The political dimension: The cuts were scheduled to take effect on July 1, 2016 - the day before the federal election [1]. This timing made the issue highly politically charged, with Labor running a "Mediscare" campaign and the Coalition defending the policy as necessary for sustainability [2].
Key context: This was not a cut to fundamental Medicare benefits but the removal of incentive payments that had only existed since 2009. The policy was partially offset by rent reforms designed to help providers maintain bulk-billing levels. Whether this represented a genuine threat to patient access or prudent fiscal management depended largely on which pathology provider a patient visited.
TRUE
7.0
out of 10
The factual assertion that the Coalition cut $650 million in bulk billing incentives for pathology is accurate. However, the claim presents this without critical context: (1) these incentives were only introduced by Labor in 2009, not long-standing entitlements; (2) the government struck a deal with Pathology Australia on rent reforms to offset the impact; (3) the policy was driven by concerns that large corporate providers were using incentives to subsidise business costs rather than patient care; and (4) with 99% bulk-billing rates, there were legitimate questions about whether these incentives were still necessary.
Final Score
7.0
OUT OF 10
TRUE
The factual assertion that the Coalition cut $650 million in bulk billing incentives for pathology is accurate. However, the claim presents this without critical context: (1) these incentives were only introduced by Labor in 2009, not long-standing entitlements; (2) the government struck a deal with Pathology Australia on rent reforms to offset the impact; (3) the policy was driven by concerns that large corporate providers were using incentives to subsidise business costs rather than patient care; and (4) with 99% bulk-billing rates, there were legitimate questions about whether these incentives were still necessary.
📚 SOURCES & CITATIONS (4)
-
1
Bulk billing incentives for pathologists to be scrapped on day before election, Sussan Ley says
Federal Health Minister Sussan Ley says she will not give into Labor's "scare campaign" against a policy to scrap bulk billing incentives for pathologists — even if it coincides with an election.
Abc Net -
2
Election FactCheck: has the Coalition cut bulk-billing for pathology and scans 'to make patients pay more'?
Labor’s shadow health minister Catherine King, said that the government has “cut bulk-billing payments for pathology and diagnostic imaging to make patients pay more”. Is that right?
The Conversation -
3
What's In The Pathology Deal For Sonic And Primary?
The government and Pathology Australia have struck a deal on collection centre rents and brokers look at the implications for pathology providers.
FNArena.com -
4
PM's omission misleads on Medicare rebate claim
Anthony Albanese failed to mention that Labor initiated a rebate freeze when naming Peter Dutton as the man responsible.
Aap Com
Rating Scale Methodology
1-3: FALSE
Factually incorrect or malicious fabrication.
4-6: PARTIAL
Some truth but context is missing or skewed.
7-9: MOSTLY TRUE
Minor technicalities or phrasing issues.
10: ACCURATE
Perfectly verified and contextually fair.
Methodology: Ratings are determined through cross-referencing official government records, independent fact-checking organizations, and primary source documents.